ScholarIQanswers from OpenAlex

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis

PaperCitations, authors & open-access status

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis have?

ScholarIQcitation count

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis has 240 citations in the OpenAlex counts ScholarIQ stores.

When was Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis published?

ScholarIQyear

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis has 2010 year in the ScholarIQ index.

What is the open-access status of Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis?

ScholarIQoa status

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis has green oa status in the ScholarIQ index.

What is the DOI of Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis?

ScholarIQdoi

The DOI for Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis is on the source record.

What is the PMID of Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis?

ScholarIQpmid

The PMID for Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis is on the source record.

What is the OpenAlex record for Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis?

ScholarIQopenalex

The OpenAlex for Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial